Pulse Biosciences, Inc. (PLSE) Financial Statements
Pulse Biosciences, Inc. (PLSE) reported trailing twelve-month revenue of $1.2M (up 178.0% year on year) and net income of -$80.1M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$61.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PLSEPulse Biosciences, Inc.Follow PLSE — free
—
Price chart with a free account
- Market cap
- 3.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Revenue | 1.4 | 0.7 | 0.4 | 1.2 | |
| Gross profit | -0.6 | -11.2 | -0.2 | — | |
| Research & development | 28.6 | 20.8 | 44.7 | 51.9 | |
| Operating income | -63.0 | -58.1 | -76.9 | -83.0 | |
| Pre-tax income | -63.7 | -58.5 | 72.8 | — | |
| Income tax | 0.0 | 0.0 | 0.0 | — | |
| Net income | -63.7 | -58.5 | -72.8 | -80.1 | |
| Diluted EPS ($) | -2.28 | — | — | — |
USD millions · SEC XBRL
Pulse Biosciences, Inc. — questions
- What is Pulse Biosciences, Inc.'s revenue?
- $1.2M over the twelve months to 2026-06-30, up 178.0% year on year, from its 10-Q and 10-K filings.
- What is Pulse Biosciences, Inc.'s net income?
- -$80.1M over the twelve months to 2026-06-30.
- What is Pulse Biosciences, Inc.'s free cash flow?
- -$61.4M over the twelve months to 2026-06-30.
Every figure on this page comes from Pulse Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.